The S2 accessory gene of equine infectious anemia virus is essential for expression of disease in ponies

Virology

Volumn 349, Issue 1, 2006, Pages 22-30

  Fagerness, Angela J ^a   Flaherty, Maureen T ^a   Perry, Stephanie T ^a   Jia, Bin ^a   Payne, Susan L ^b   Fuller, Frederick J ^a  

^a NORTH CAROLINA STATE UNIVERSITY   (United States)

^b TEXAS A AND M UNIVERSITY   (United States)

Author keywords

Accessory gene deletion; Equine infectious anemia virus; Pathogenesis mutant; S2 accessory gene; Viral pathogenesis

Indexed keywords

ANIMAL CELL; ARTICLE; BLOOD ANALYSIS; CONTROLLED STUDY; EQUINE INFECTIOUS ANEMIA VIRUS; FETUS; GENE EXPRESSION; GENE MUTATION; HORSE; MOLECULAR CLONING; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; S2 ACCESSORY GENE; VIRUS GENE; VIRUS LOAD; VIRUS VIRULENCE;

AMINO ACID SEQUENCE; ANIMALS; BLOOD; BODY TEMPERATURE; CELL LINE; DOGS; EQUINE INFECTIOUS ANEMIA; GENE DELETION; GENES, ESSENTIAL; GENES, VIRAL; HORSES; INFECTIOUS ANEMIA VIRUS, EQUINE; MACROPHAGES; MUTAGENESIS, SITE-DIRECTED; RNA-DIRECTED DNA POLYMERASE; SEQUENCE HOMOLOGY; VIRAL LOAD; VIRAL PROTEINS; VIRUS REPLICATION;

ANIMALIA; EQUIDAE; EQUINE INFECTIOUS ANEMIA VIRUS; EQUUS CABALLUS; LENTIVIRUS;

EID: 33646521496     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2005.12.041     Document Type: Article

References (38)

1. Arold S.T., and Baur A.S. Dynamic nef and nef dynamics: how structure could explain the complex activities of this small HIV protein. Trends Biochem. Sci. 26 (2001) 356-363
2. Beisel C.E., Edwards J.F., Dunn L.L., and Rice N.R. Analysis of multiple mRNAs from pathogenic equine infectious anemia virus (EIAV) in an acutely infected horse reveals a novel protein, ttm derived from the carboxy terminus of the EIAV transmembrane protein. J. Virol. 67 (1993) 832-834
3. Carl S., Iafrate A.J., Lang S.M., Stolte N., Matz-Rensing K., Fuchs D., Stahl-Hennig C., Skowronski J., and Kirchhoff F. Simian immunodeficiency virus containing mutations in N-terminal tyrosine residues and in the PxxP motif in Nef replicates efficiently in rhesus macaques. J. Virol. 74 (2000) 4155-4164
4. Cook R.F., Cook S.J., Berger S.L., Leroux C., Ghabrial N.N., Gantz M., Bolin P.S., Mousel M.R., Montelaro R.C., and Issel C.J. Enhancement of equine infectious anemia virus virulence by identification and removal of suboptimal nucleotides. Virology 313 (2003) 588-603
5. Corey S.J., and Anderson S.M. Src-related protein tyrosine kinases in hematopoiesis. Blood 93 (1999) 1-14
6. Cunningham T.P., Montelaro R.C., and Rushlow K.E. Lentivirus envelope sequences and proviral genomes are stabilized in Escherichia coli when cloned in low-copy-number plasmid vectors. Gene 124 (1993) 93-98
7. Deacon N.J., Tsykin A., Solomom A., Smith K., Ludford-Menting M., Hooker D.J., McPhee D.A., Greenway A.L., Ellett A., Chatfield C., Lawson V.A., Crowe S., Maerz A., Sonza S., Learmont J., Sullivan J.S., Cunningham A., Dwyer D., Dowton D., and Mills J. Genomic structure of an attenuated quasi species of HIV-1 from a blood transfusion donor and recipients. Science 270 (1995) 988-991
8. Dorn P., DaSilva L., Martarano L., and Derse D. Equine infectious anemia virus tat: insights into structure, function, and evolution of lentivirus trans-activator proteins. J. Virol. 64 (1990) 1616-1624
9. Greenberg M.E., Iafrate A.J., and Skowronski J. The SH3 domain-binding surface and an acidic motif in HIV-1 Nef regulate trafficking of class 1 MHC complexes. EMBO J. 17 (1998) 2777-2789
10. Issel C.J., and Coggins L. Equine infectious anemia: current knowledge. JAVMA 174 (1979) 727-737
11. Kim C.H., and Casey J.W. In vivo replicative status and envelope heterogeneity of equine infectious anemia virus in an inapparent carrier. J. Virol. 68 (1994) 2777-2780
12. Kirchhoff F., Greenough T.C., Brettler D.B., Sullivan J.L., and Desrosiers R.C. Brief report: absence of intact nef sequences in a long-term survivor with nonprogressive HIV-1 infection. N. Engl. J. Med. 332 (1995) 228-232
13. Kono Y. Viremia and immunological responses in horses infected with equine infectious anemia virus. Natl. Inst. Anim. Health Q 9 (1969) 1-9
14. Kono Y. Recurrences of equine infectious anemia. Proc. 3rd Conf. Equine Infect. (1973) 175-186
15. Kono Y., Kobayashi K., and Fukunaga Y. Antigenic drift of equine infectious anemia virus in chronically infected horses. Arch. Gesamte Virusforch. 41 (1973) 1-10
16. Kono Y., Hirasawa K., Fukunaga Y., and Taniguchi T. Recrudescence of equine infectious anemia by treatment with immunosuppressive drugs. Natl. Inat. Anim. Health Q 16 (1975) 667-674
17. Lang S.M., Iafrate A.J., Stahl-Hennig C., Kuhn E.M., NiBlein T., Haupt M., Hunsmann G., Skowronski J., and Kirchhoff F. Association of simian immunodeficiency virus Nef with cellular serine/threonine kinases is dispensable for the development of AIDS in rhesus macaques. Nat. Med. 3 (1997) 860-865
18. Langemeier J.L., Cook S.J., Cook R.F., Rushlow K.E., Montelaro R.C., and Issel C.J. Detection of equine infectious anemia viral RNA in plasma samples from recently infected and long-term inapparent carrier animals by PCR. J. Clin. Microbiol. 34 (1996) 1481-1487
19. Li F., Puffer B.A., and Montelaro R.C. S2 gene of equine infectious anemia virus is dispensable for viral replication in vitro. J. Virol. 72 (1998) 8344-8348
20. Li F., Leroux C., Craigo J.K., Cook S.J., Issel C.J., and Montelaro R.C. The S2 gene of equine infectious anemia virus is a highly conserved determinant of viral replication and virulence properties in experimentally infected ponies. J. Virol. 74 (2000) 573-579
21. Li F., Craigo J.K., Howe L., Steckbeck J.D., Cook S., Issel C., and Montelaro R.C. A live attenuated equine infectious anemia virus proviral vaccine with a modified S2 gene provides protection from detectable infection by intravenous virulent virus challenge of experimentally inoculated horses. J. Virol. 77 (2003) 7244-7253
22. Macdonald A., Crowder K., Street A., McCormick C., and Harris M. The hepatitis C virus NS5A protein binds to members of the Src family of tyrosine kinases and regulates kinase activity. J. Gen. Virol. 85 (2004) 721-729
23. Martanaro L., Stephens R., Rice N., and Derse D. Equine infectious anemia virus trans-regulatory protein Rev controls viral mRNA stability, accumulation, and alternative splicing. J. Virol. 68 (1994) 3102-3111
24. Noiman S., Gazit A., Tori O., Sherman L., Miki T., Tronick S.R., and Yaniv A. Identification of sequences encoding the equine infectious anemia virus tat gene. Virology 176 (1990) 280-288
25. Payne S.L., Qi X., Shao H., Dwyer A., and Fuller F.J. Disease induction by virus derived from molecular clones of equine infectious anemia virus. J. Virol. 74 (1998) 483-487
26. Perry S.T., Flaherty M.T., Kelley M.J., Clabough D.L., Tronick S.R., Coggins L., Whetter L., Lengel C.R., and Fuller F. The surface envelope protein gene of equine infectious anemia virus is not an important determinant of tropism in vitro. J. Virol. 66 (1992) 4085-4097
27. Salinovich O., Payne S.L., Montalero R.C., Hussain K.A., Issel C.J., and Schnorr K.L. Rapid emergence of novel antigenic and genetic variants of equine infectious anemia virus during persistent infection. J. Virol. 57 (1986) 71-80
28. Schiltz R.L., Shih D.S., Rasty S., Montelaro R.C., and Rushlow K.E. Equine infectious anemia virus gene expression: characterization of the RNA splicing pattern and the proteins products encoded by open reading frames S1 and S2. J. Virol. 66 (1992) 3455-3465
29. Schindler M., Munch J., Brenner M., Stahl-Hennig C., Skowronski J., and Kirchhoff F. Comprehensive analysis of nef functions selected in simian immunodeficiency virus-infected macaques. J. Virol. 78 (2004) 10588-10597
30. Springer T.A. Immunoprecipitation. In: Coligan J.E., Kruisbeck A.M., Margulies D.H., Shevach E.M., and Strober W. (Eds). Current Protocols in Immunology (1996), John Wiley and Sons, New York 8.3.1-8.3.11
31. Steagall W.K., Robek M.D., Perry S.T., Fuller F.J., and Payne S.L. Incorporation of uracil into viral DNA correlates with reduced replication of EIAV in macrophages. Virology 210 (1995) 302-313
32. Targowski S.P. Separation of mononuclear leukocytes and polymorphonuclear leukocytes from equine blood. Can. J. Comp. Med. 40 (1976) 285-290
33. Threadgill D.S., Steagall W.K., Flaherty M.T., Fuller F.J., Perry S.T., Rushlow K.E., Le Grice S.F.J., and Payne S.L. Characterization of equine infectious anemia virus dUTPase: growth properties of a dUTPase-deficient mutant. J. Virol. 67 (1993) 2592-2600
34. Towler D.A., Gordon J.I., Adams S.P., and Glaser L. The biology and enzymology of eukaryotic protein acylation. Annu. Rev. Biochem. 57 (1988) 69-99
35. Tumas D.B., Hines M.T., Perryman L.E., Davis W.C., and McGuire T.C. Corticosteroid immunosuppression and monoclonal antibody-mediated CD5+ T lymphocyte depletion in normal and equine infectious anemia virus-carrier horses. J. Gen. Virol. 75 (1994) 959-968
36. Wente S.R., and Blobel G. NUP145 encodes a novel yeast glycine-leucine-phenylalanine-glycine (GLFG) nucleoporin required for nuclear envelope structure. J. Cell. Biol. 125 (1994) 955-969
37. Whetter L., Archambault D., Perry S., Gazit A., Coggins L., Yaniv A., Clabough D., Dahlberg J., Fuller F., and Tronick S. Equine infectious anemia virus derived from a molecular clone persistently infects horses. J. Virol. 64 (1990) 5750-5756
38. Yoon S., Kingsman S.M., Kingsman A.J., Wilson S.A., and Mitrophanous K.A. Characterization of the equine infectious anaemia virus S2 protein. J. Gen. Virol. 81 (2000) 2189-2194